폐외결핵 환자에서의 항결핵제 내성
Drug-Resistant Extrapulmonary Tuberculosis
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
The prevalence and pattern of drug-resistant extrapulmonary tuberculosis (TB) is not well characterized in Korea. Therefore, we assessed the incidence of drug resistance for extrapulmonary TB in adult patients at a tertiary hospital. We retrospectively reviewed the medical records and results of drug susceptibility test in all culture-confirmed extapulmonary TB patients during an 18-month period. Out of a total of 168 cases in which the drug susceptibility test was performed, resistance to at least one anti-TB drug was found in 15 cases (8.9%), and multidrug resistance, in which TB was resistant to at least isoniazid and rifampin, was found in 3 cases (1.8%).
Abstract
The prevalence and pattern of drug-resistant extrapulmonary tuberculosis (TB) is not well characterized in Korea. Therefore, we assessed the incidence of drug resistance for extrapulmonary TB in adult patients at a tertiary hospital. We retrospectively reviewed the medical records and results of drug susceptibility test in all culture-confirmed extapulmonary TB patients during an 18-month period. Out of a total of 168 cases in which the drug susceptibility test was performed, resistance to at least one anti-TB drug was found in 15 cases (8.9%), and multidrug resistance, in which TB was resistant to at least isoniazid and rifampin, was found in 3 cases (1.8%).
참고문헌 (15)
- "Anti-tuberculous drug resistance surveillance in Korea"[URL]
- Peto HM, "Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006", Clin Infect Dis, 49, pp.1350~1357 (2009)
- 박우일, "폐외결핵의 임상양상과 진단에 대한 고찰", Infection and Chemotherapy, 34(1), pp.47~54 (2002), 대한감염학회
- Kim SH, "Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis", Arch Intern Med, 167, pp.2255~2259 (2007)
- Cho OH, "Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis", JOURNAL OF INFECTION, 59(1), pp.56~61 (2009), W B SAUNDERS CO LTD
- Lin JN, "Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis", Int J Tuberc Lung Dis, 13, pp.620~625 (2009)
- Yang Z, "Identification of risk factors for extrapulmonary tuberculosis", Clin Infect Dis, 38, pp.199~205 (2004)
- Global tuberculosis control: surveillance, planning, financing, "World Health Organization", WHO, ~, pp.WHO (2006), HTM[DOI]
- Cheng VC, "Risk factors for development of paradoxical response during antituberculosis therapy in HIVnegative patients", Eur J Clin Microbiol Infect Dis, 22, pp.597~602 (2003)
- 송은주, "결핵흉막염 치료 중에 발생한 역설적 반응에 대한 연구", Tuberculosis and Respiratory Diseases, 64(6), pp.427~432 (2008), 대한결핵및호흡기학회
- Al-Majed SA, "Study of paradoxical response to chemotherapy in tuberculous pleural effusion", Respir Med, 90, pp.211~214 (1996)
- Bai GH, "Trend of anti-tuberculosis drug resistance in Korea, 1994-2004", Int J Tuberc Lung Dis, 11, pp.571~576 (2007)
- 김민재, "Prevalence and Its Predictors of Extrapulmonary Involvement in Patients with Pulmonary Tuberculosis", Journal of Korean Medical Science, 24(2), pp.237~241 (2009), 대한의학회
- 공재환, "초치료 폐결핵 환자들에 있어서 초회 약제내성률", Tuberculosis and Respiratory Diseases, 64(2), pp.95~101 (2008), 대한결핵및호흡기학회
- Yang H, "Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility", Int J Tuberc Lung Dis, 9, pp.288~293 (2005)